Barclays PLC Schedule 13G passive stakes

Barclays PLC has filed a Schedule 13G, disclosing a beneficial ownership of 870,255 shares, representing 4.81% of the outstanding common stock of Crown Reserve Acquisition Company.

Barclays PLC has filed an amendment to its Schedule 13G, reporting a beneficial ownership of 7,233 shares, representing 0.02% of Cartesian Therapeutics Inc.'s common stock.

Barclays PLC has updated its beneficial ownership filing for JELD-WEN Holding Inc., reporting a 6.86% stake as of September 30, 2026.

Barclays PLC has filed an amendment to its Schedule 13G, reporting beneficial ownership of 4.00% of Mercer International Inc.'s common stock as of September 30, 2026.

Barclays PLC has updated its beneficial ownership filing for Penumbra Inc., reporting a 4.82% stake as of September 30, 2026.

Barclays PLC has updated its Schedule 13G filing to report beneficial ownership of 7.16% of Office Properties Income REIT's common stock.

Barclays PLC has filed an amendment to its Schedule 13G, reporting a substantial decrease in its beneficial ownership of Commerce.com Inc. common stock.

Barclays PLC has filed a Schedule 13G, disclosing beneficial ownership of 2.11% of Calisa Acquisition Corp's common stock as of September 30, 2026.

Barclays PLC has filed a Schedule 13G, reporting beneficial ownership of 93,900 shares, representing 1.46% of the class of securities in Silverbox Corp IV-A.

Barclays PLC has reported a beneficial ownership of 1,145,170 shares, representing 3.38% of the outstanding common stock of Forward Air Corp.

Barclays PLC has disclosed a beneficial ownership of 338,307 shares, representing 5.96% of Cable One Inc.'s common stock, as of September 30, 2026.

Barclays PLC has disclosed beneficial ownership of 1,207,500 units, representing 8.05% of the class, in Bluerock Acquisition Corp II.

Barclays PLC has reported a beneficial ownership of 6.99% in Cannae Holdings Inc. as of September 30, 2026.

Barclays PLC has disclosed beneficial ownership of 108,962 shares, representing 5.15% of the common stock in Biglari Holdings Inc-B.

Barclays PLC has disclosed beneficial ownership of 5.02% of Digital Asset Acquisiti-CL A's common stock as of September 30, 2026.

Barclays PLC has disclosed beneficial ownership of 5.60% of Quantum Corp's common stock as of September 30, 2026.

Barclays PLC has disclosed beneficial ownership of 5.55% of Enviro Corp's common stock as of September 30, 2026.

Barclays PLC has updated its beneficial ownership filing for Shenandoah Telecommunication, reporting a 5.76% stake as of September 30, 2026.

Barclays PLC has filed a Schedule 13G, reporting beneficial ownership of 5.48% of Aldeyra Therapeutics Inc. common stock as of September 30, 2026.

Barclays PLC has disclosed beneficial ownership of 6.04% of New Fortress Energy's common stock as of September 30, 2026.

Barclays PLC has disclosed beneficial ownership of 1,379,923 units, representing 6.82% of Pinnacle Acquisition Corp's class of securities, as of September 30, 2026.

Barclays PLC has disclosed beneficial ownership of 7.00% of Haymaker Acquisition Corp-U's units, holding 2,012,500 shares.

Barclays PLC has filed a Schedule 13G, reporting beneficial ownership of 5.00% of Weave Communications Inc. common stock as of September 30, 2026.

Barclays PLC has filed a Schedule 13G, disclosing beneficial ownership of 6.13% of Live Oak Acquisition Corp VI's units.

Barclays PLC has filed a Schedule 13G, reporting a beneficial ownership of 5.49% in Box Inc. Class A Common Stock as of September 30, 2026.

Barclays PLC has updated its Schedule 13G filing to reflect beneficial ownership of 3.36% in QVC Group Inc. common stock.

Barclays PLC has disclosed beneficial ownership of 5,106,642 shares, representing 10.2% of QVC Group Inc.'s common stock, as of August 31, 2026.

Barclays PLC has disclosed beneficial ownership of 273,125 shares, representing 6.74% of the outstanding common stock in Rising Dragon Acquisition Co.

Barclays PLC has filed a Schedule 13G, disclosing a minimal beneficial ownership of 20 shares in Reviva Pharmaceuticals, representing 0.00% of the class.

Barclays PLC has filed a Schedule 13G, reporting a beneficial ownership of 0.17% in Tavia Acquisition Corp's common stock as of June 30, 2026.